Sign In
Buy LNSR
$5.66
-0.0800 (-1.39%)
At Close: Jun 22, 2026
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:34pm, Monday, 03'rd Jun 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted three
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
08:00am, Thursday, 23'rd May 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
LENSAR, Inc. (LNSR) Q1 2024 Earnings Call Transcript
03:50pm, Saturday, 11'th May 2024
LENSAR, Inc. (NASDAQ:LNSR ) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nicholas Curtis - CEO Thomas Staab - CFO Conference Call Participant
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
08:00am, Thursday, 02'nd May 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:38pm, Wednesday, 01'st May 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted two ne
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:28pm, Monday, 01'st Apr 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted three
LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript
10:36am, Monday, 04'th Mar 2024
LENSAR, Inc. (NASDAQ:LNSR ) Q4 2023 Earnings Conference Call March 4, 2024 8:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nicholas Curtis - Chief Executive Officer Thomas Staab -
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
07:00am, Monday, 04'th Mar 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:01pm, Friday, 01'st Mar 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”) today announced that a majority of the independent members of LENSAR's board of directors granted seven
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
08:00am, Monday, 26'th Feb 2024
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
LENSAR, Inc. (LNSR) Q3 2023 Earnings Call Transcript
12:32pm, Saturday, 11'th Nov 2023
LENSAR, Inc. (NASDAQ:LNSR ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nicholas Curtis - CEO Thomas Staab - CFO Conference Ca
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
07:00am, Thursday, 09'th Nov 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
08:03am, Thursday, 02'nd Nov 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
LENSAR, Inc. (LNSR) Q2 2023 Earnings Call Transcript
06:04pm, Friday, 11'th Aug 2023
LENSAR, Inc. (NASDAQ:LNSR ) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Company Participants Cameron Radinovic – Burns McClellan Nick Curtis – Chief Executive Officer Tom Staab –
LENSAR Reports Second Quarter 2023 Results and Provides Business Update
07:00am, Wednesday, 09'th Aug 2023
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment o
